The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.
McLoughlin LC, O'Halloran S, Tjong M, Ajib K, Lajkosz K, Ruff H, Lou S, Chung P, Raman S, Kulkarni GS, Zlotta AR, Fleshner NE, Berlin A.
McLoughlin LC, et al.
Urol Oncol. 2022 Jul;40(7):346.e9-346.e16. doi: 10.1016/j.urolonc.2022.02.021. Epub 2022 Apr 4.
Urol Oncol. 2022.
PMID: 35393232